| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.002 | 0.937 | DNA synthesis inhibitor | 0.937 0.001 DBMET00718 0.898 0.002 DBMET00720 | DBMET00718 | |
| 0.885 | 0.001 | 0.885 | RNA-directed DNA polymerase inhibitor | 0.696 0.003 DBMET00718 0.722 0.002 DBMET00720 | ||
| 0.873 | 0 | 0.873 | Thymidine phosphorylase inhibitor | 0.26 0.002 DBMET00718 0.529 0.001 DBMET00720 | ||
| 0.835 | 0.001 | 0.835 | Thymidine kinase inhibitor | 0.211 0.003 DBMET00718 0.514 0.001 DBMET00720 | ||
| 0.836 | 0.007 | 0.836 | Caspase 9 stimulant | 0.817 0.009 DBMET00718 0.514 0.054 DBMET00720 | ||
| 0.749 | 0.003 | 0.749 | DNA directed RNA polymerase inhibitor | 0.472 0.004 DBMET00718 0.545 0.004 DBMET00720 | ||
| 0.738 | 0.003 | 0.738 | Cytidine deaminase inhibitor | 0.33 0.015 DBMET00718 0.565 0.005 DBMET00720 | ||
| 0.645 | 0 | 0.645 | Uridine phosphorylase inhibitor | 0.336 0.001 DBMET00718 0.366 0.001 DBMET00720 | ||
| 0.665 | 0.041 | 0.665 | DNA directed DNA polymerase inhibitor | 0.599 0.055 DBMET00718 0.438 0.102 DBMET00720 | ||
| 0.625 | 0.003 | 0.625 | HIV-1 reverse transcriptase inhibitor | 0.412 0.004 DBMET00718 0.399 0.004 DBMET00720 | ||
| 0.524 | 0.012 | 0.621 | DNA damaging | 0.621 0.007 DBMET00718 0.425 0.023 DBMET00720 | DBMET00718 | |
| 0.495 | 0.003 | 0.548 | UDP-glucose 4-epimerase inhibitor | 0.399 0.006 DBMET00718 0.548 0.002 DBMET00720 | DBMET00720 | |
| 0.495 | 0.042 | 0.666 | Antibacterial | 0.666 0.012 DBMET00718 0.578 0.023 DBMET00720 | DBMET00718 | |
| 0.457 | 0.035 | 0.672 | Immunostimulant | 0.672 0.01 DBMET00718 0.426 0.043 DBMET00720 | DBMET00718 | |
| 0.366 | 0.001 | 0.366 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.043 0.004 DBMET00718 0.236 0.001 DBMET00720 | ||
| 0.372 | 0.01 | 0.373 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET00718 0.373 0.01 DBMET00720 | DBMET00720 | |
| 0.354 | 0.012 | 0.432 | Peptidyltransferase inhibitor | 0.432 0.005 DBMET00718 0.386 0.008 DBMET00720 | DBMET00718 | |
| 0.347 | 0.008 | 0.422 | DNA polymerase I inhibitor | 0.324 0.009 DBMET00718 0.422 0.005 DBMET00720 | DBMET00720 | |
| 0.314 | 0.005 | 0.32 | Protein kinase C mu inhibitor | 0.184 0.015 DBMET00718 0.32 0.005 DBMET00720 | DBMET00720 | |
| 0.298 | 0.003 | 0.298 | Carbonic anhydrase VB inhibitor | 0.198 0.005 DBMET00720 | ||
| 0.28 | 0.004 | 0.394 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.148 0.009 DBMET00718 0.394 0.002 DBMET00720 | DBMET00720 | |
| 0.271 | 0.006 | 0.526 | Antimetabolite | 0.233 0.008 DBMET00718 0.526 0.002 DBMET00720 | DBMET00720 | |
| 0.286 | 0.033 | 0.314 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.314 0.02 DBMET00720 | DBMET00720 | |
| 0.252 | 0.006 | 0.252 | Protein kinase C gamma inhibitor | 0.201 0.014 DBMET00720 | ||
| 0.312 | 0.073 | 0.423 | Caspase 3 stimulant | 0.423 0.038 DBMET00718 | DBMET00718 | |
| 0.268 | 0.031 | 0.406 | Protein kinase C nu inhibitor | 0.406 0.009 DBMET00720 | DBMET00720 | |
| 0.258 | 0.022 | 0.368 | Interleukin 6 antagonist | 0.19 0.047 DBMET00718 0.368 0.009 DBMET00720 | DBMET00720 | |
| 0.229 | 0.005 | 0.229 | Carbonic anhydrase V inhibitor | 0.155 0.013 DBMET00720 | ||
| 0.221 | 0.012 | 0.221 | Breast cancer-resistant protein inhibitor | 0.095 0.06 DBMET00718 | ||
| 0.243 | 0.039 | 0.276 | MAP kinase kinase 3 inhibitor | 0.276 0.014 DBMET00720 | DBMET00720 | |
| 0.207 | 0.004 | 0.21 | Protein kinase C eta inhibitor | 0.167 0.006 DBMET00718 0.21 0.004 DBMET00720 | DBMET00720 | |
| 0.213 | 0.014 | 0.345 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.345 0.005 DBMET00720 | DBMET00720 | |
| 0.193 | 0.005 | 0.193 | Carbonic anhydrase VA inhibitor | 0.146 0.012 DBMET00720 | ||
| 0.195 | 0.008 | 0.338 | Argininosuccinate synthase inhibitor | 0.054 0.042 DBMET00718 0.338 0.003 DBMET00720 | DBMET00720 | |
| 0.332 | 0.151 | 0.476 | Apoptosis agonist | 0.476 0.082 DBMET00718 | DBMET00718 | |
| 0.203 | 0.04 | 0.288 | Lipid peroxidase inhibitor | 0.288 0.02 DBMET00718 0.205 0.04 DBMET00720 | DBMET00718 | |
| 0.158 | 0.004 | 0.158 | Protein kinase C beta inhibitor | 0.073 0.042 DBMET00718 0.124 0.006 DBMET00720 | ||
| 0.167 | 0.015 | 0.189 | Protein kinase C delta inhibitor | 0.08 0.077 DBMET00718 0.189 0.01 DBMET00720 | DBMET00720 | |
| 0.279 | 0.128 | 0.464 | Immunosuppressant | 0.464 0.043 DBMET00718 0.24 0.156 DBMET00720 | DBMET00718 | |
| 0.152 | 0.01 | 0.186 | Protein kinase C alpha inhibitor | 0.071 0.042 DBMET00718 0.186 0.006 DBMET00720 | DBMET00720 | |
| 0.174 | 0.045 | 0.174 | Interleukin 1 antagonist | |||
| 0.181 | 0.06 | 0.223 | MAP kinase kinase 5 inhibitor | 0.223 0.015 DBMET00720 | DBMET00720 | |
| 0.2 | 0.079 | 0.363 | DNA methylase inhibitor | 0.135 0.132 DBMET00718 0.363 0.015 DBMET00720 | DBMET00720 | |
| 0.135 | 0.024 | 0.147 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.056 DBMET00718 0.147 0.02 DBMET00720 | DBMET00720 | |
| 0.126 | 0.016 | 0.126 | Ribonucleotide reductase inhibitor | 0.095 0.022 DBMET00720 | ||
| 0.162 | 0.054 | 0.234 | Cell wall synthesis inhibitor | 0.234 0.019 DBMET00718 0.194 0.032 DBMET00720 | DBMET00718 | |
| 0.169 | 0.062 | 0.177 | Cyclin-dependent kinase 3 inhibitor | 0.177 0.052 DBMET00720 | DBMET00720 | |
| 0.106 | 0.002 | 0.106 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.078 0.002 DBMET00720 | ||
| 0.14 | 0.042 | 0.222 | DNA repair enzyme inhibitor | 0.156 0.026 DBMET00718 0.222 0.007 DBMET00720 | DBMET00720 | |
| 0.119 | 0.029 | 0.223 | NADH dehydrogenase inhibitor | 0.202 0.01 DBMET00718 0.223 0.009 DBMET00720 | DBMET00720 | |
| 0.263 | 0.174 | 0.379 | MAP kinase kinase 6 inhibitor | 0.379 0.071 DBMET00720 | DBMET00720 | |
| 0.147 | 0.064 | 0.176 | MAP3K9 inhibitor | 0.176 0.03 DBMET00720 | DBMET00720 | |
| 0.167 | 0.088 | 0.314 | DNA methyltransferase I inhibitor | 0.314 0.022 DBMET00720 | DBMET00720 | |
| 0.158 | 0.089 | 0.176 | Death-associated protein kinase 2 inhibitor | 0.176 0.059 DBMET00720 | DBMET00720 | |
| 0.093 | 0.025 | 0.093 | HIV-1 integrase (Strand Transfer) inhibitor | 0.087 0.028 DBMET00718 | ||
| 0.099 | 0.032 | 0.22 | Phosphofructokinase-1 inhibitor | 0.115 0.026 DBMET00718 0.22 0.009 DBMET00720 | DBMET00720 | |
| 0.076 | 0.009 | 0.124 | Thymidylate synthase inhibitor | 0.124 0.004 DBMET00720 | DBMET00720 | |
| 0.103 | 0.036 | 0.154 | Transcription factor NF kappa B stimulant | 0.154 0.015 DBMET00718 0.094 0.045 DBMET00720 | DBMET00718 | |
| 0.126 | 0.062 | 0.192 | Alkylator | 0.147 0.048 DBMET00718 0.192 0.029 DBMET00720 | DBMET00720 | |
| 0.219 | 0.158 | 0.404 | Interleukin 2 agonist | 0.404 0.026 DBMET00718 0.266 0.102 DBMET00720 | DBMET00718 | |
| 0.208 | 0.148 | 0.308 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.308 0.058 DBMET00720 | DBMET00720 | |
| 0.08 | 0.025 | 0.127 | Neuraminidase (influenza) inhibitor | 0.127 0.01 DBMET00718 | DBMET00718 | |
| 0.08 | 0.028 | 0.08 | Adenosine A1 receptor antagonist | 0.077 0.03 DBMET00720 | ||
| 0.078 | 0.027 | 0.175 | Biliverdin reductase inhibitor | 0.175 0.007 DBMET00720 | DBMET00720 | |
| 0.077 | 0.028 | 0.104 | Neuraminidase inhibitor | 0.104 0.014 DBMET00718 | DBMET00718 | |
| 0.137 | 0.087 | 0.261 | NOS3 expression enhancer | 0.261 0.024 DBMET00718 0.193 0.044 DBMET00720 | DBMET00718 | |
| 0.084 | 0.035 | 0.084 | HIV-1 integrase inhibitor | |||
| 0.061 | 0.02 | 0.069 | Adenosine deaminase inhibitor | 0.044 0.036 DBMET00718 0.069 0.014 DBMET00720 | DBMET00720 | |
| 0.045 | 0.005 | 0.045 | Protein kinase C beta I inhibitor | 0.041 0.008 DBMET00718 0.044 0.006 DBMET00720 | ||
| 0.041 | 0.005 | 0.041 | DNA polymerase III inhibitor | 0.035 0.008 DBMET00718 0.032 0.011 DBMET00720 | ||
| 0.062 | 0.025 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 DBMET00718 0.069 0.016 DBMET00720 | DBMET00718 | |
| 0.079 | 0.044 | 0.086 | Adenosine A3 receptor antagonist | 0.086 0.036 DBMET00720 | DBMET00720 | |
| 0.045 | 0.013 | 0.054 | Purinergic P2Y2 antagonist | 0.054 0.009 DBMET00720 | DBMET00720 | |
| 0.087 | 0.055 | 0.105 | Hematopoietic | 0.105 0.031 DBMET00720 | DBMET00720 | |
| 0.107 | 0.078 | 0.131 | Microtubule formation inhibitor | 0.131 0.05 DBMET00718 | DBMET00718 | |
| 0.039 | 0.012 | 0.039 | Protein kinase C beta II inhibitor | 0.037 0.014 DBMET00720 | ||
| 0.128 | 0.106 | 0.22 | Hexokinase inhibitor | 0.133 0.1 DBMET00718 0.22 0.025 DBMET00720 | DBMET00720 | |
| 0.065 | 0.043 | 0.066 | HIV-1 integrase (3'-Processing) inhibitor | 0.066 0.042 DBMET00718 | DBMET00718 | |
| 0.04 | 0.021 | 0.063 | Antibiotic Aminoglycoside-like | 0.063 0.008 DBMET00718 0.055 0.01 DBMET00720 | DBMET00718 | |
| 0.019 | 0.002 | 0.019 | Purinergic P2Y2 agonist | 0.018 0.002 DBMET00718 0.017 0.002 DBMET00720 | ||
| 0.02 | 0.007 | 0.02 | Purinergic P2 agonist | 0.018 0.008 DBMET00718 0.02 0.007 DBMET00720 | ||
| 0.02 | 0.007 | 0.02 | Purinergic receptor agonist | 0.018 0.008 DBMET00718 0.02 0.007 DBMET00720 | ||
| 0.025 | 0.015 | 0.03 | Adenosine A1 receptor agonist | 0.022 0.019 DBMET00718 0.03 0.012 DBMET00720 | DBMET00720 | |
| 0.015 | 0.007 | 0.015 | Purinergic P2Y agonist | 0.014 0.008 DBMET00718 0.015 0.006 DBMET00720 | ||
| 0.048 | 0.043 | 0.142 | Protein kinase C epsilon inhibitor | 0.142 0.007 DBMET00720 | DBMET00720 | |
| 0.005 | 0.001 | 0.005 | Purinergic P2Y6 agonist | 0.004 0.002 DBMET00718 0.003 0.002 DBMET00720 | ||
| 0.039 | 0.038 | 0.121 | Phosphorylase inhibitor | 0.121 0.01 DBMET00720 | DBMET00720 | |
| 0.148 | 0.147 | 0.268 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.268 0.052 DBMET00720 | DBMET00720 | |
| 0.041 | 0.041 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.048 0.027 DBMET00718 0.057 0.015 DBMET00720 | DBMET00720 | |
| 0.014 | 0.018 | 0.017 | Adenosine A3 receptor agonist | 0.017 0.013 DBMET00720 | DBMET00720 | |
| 0.05 | 0.055 | 0.108 | Carbamoyl phosphate synthetase inhibitor | 0.108 0.018 DBMET00720 | DBMET00720 | |
| 0.145 | 0.162 | 0.23 | Cyclic AMP phosphodiesterase inhibitor | 0.23 0.074 DBMET00720 | DBMET00720 | |
| 0.093 | 0.112 | 0.138 | Alpha-N-acetylglucosaminidase inhibitor | 0.138 0.063 DBMET00720 | DBMET00720 | |
| 0.015 | 0.035 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.014 DBMET00720 | DBMET00720 | |
| 0.044 | 0.065 | 0.072 | Protein kinase C iota inhibitor | 0.072 0.03 DBMET00720 | DBMET00720 | |
| 0.054 | 0.079 | 0.142 | Antineoplastic antibiotic | 0.142 0.033 DBMET00718 0.12 0.038 DBMET00720 | DBMET00718 | |
| 0.08 | 0.107 | 0.177 | Adenylate cyclase inhibitor | 0.177 0.031 DBMET00720 | DBMET00720 | |
| 0.021 | 0.051 | 0.043 | Fumarate hydratase inhibitor | 0.043 0.017 DBMET00720 | DBMET00720 | |
| 0.055 | 0.088 | 0.103 | Glutamate dehydrogenase inhibitor | 0.103 0.029 DBMET00720 | DBMET00720 | |
| 0.069 | 0.104 | 0.151 | Topoisomerase I inhibitor | 0.143 0.044 DBMET00718 0.151 0.041 DBMET00720 | DBMET00720 | |
| 0.038 | 0.076 | 0.048 | Alpha-mannosidase inhibitor | 0.048 0.047 DBMET00720 | DBMET00720 | |
| 0.058 | 0.096 | 0.095 | Protein kinase A inhibitor | 0.095 0.049 DBMET00720 | DBMET00720 | |
| 0.014 | 0.053 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.015 DBMET00718 0.022 0.02 DBMET00720 | DBMET00718 | |
| 0.029 | 0.071 | 0.067 | Ornithine carbamoyltransferase inhibitor | 0.067 0.027 DBMET00720 | DBMET00720 | |
| 0.116 | 0.16 | 0.318 | Hepatoprotectant | 0.318 0.025 DBMET00718 | DBMET00718 | |
| 0.076 | 0.125 | 0.143 | Mucolytic | 0.143 0.036 DBMET00720 | DBMET00720 | |
| 0.029 | 0.082 | 0.087 | Protein 50S ribosomal subunit inhibitor | 0.087 0.017 DBMET00718 | DBMET00718 | |
| 0.104 | 0.156 | 0.465 | Angiogenesis stimulant | 0.465 0.014 DBMET00718 | DBMET00718 | |
| 0.011 | 0.067 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 DBMET00718 | DBMET00718 | |
| 0.024 | 0.08 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | 0.051 0.04 DBMET00720 | DBMET00720 | |
| 0.164 | 0.221 | 0.34 | Vasodilator, peripheral | 0.34 0.078 DBMET00720 | DBMET00720 | |
| 0.206 | 0.264 | 0.324 | Calcium channel L-type activator | 0.324 0.137 DBMET00720 | DBMET00720 | |
| 0.073 | 0.139 | 0.101 | Phosphodiesterase 6D inhibitor | 0.088 0.082 DBMET00718 0.101 0.051 DBMET00720 | DBMET00720 | |
| 0.011 | 0.083 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET00720 | DBMET00720 | |
| 0.048 | 0.138 | 0.072 | Glycine receptor antagonist | 0.072 0.071 DBMET00718 | DBMET00718 | |
| 0.078 | 0.17 | 0.144 | Interleukin 8 antagonist | 0.144 0.038 DBMET00720 | DBMET00720 | |
| 0.141 | 0.238 | 0.454 | Transcription factor NF kappa B inhibitor | 0.454 0.052 DBMET00718 | DBMET00718 | |
| 0.117 | 0.215 | 0.385 | Antioxidant | 0.385 0.038 DBMET00718 | DBMET00718 | |
| 0.012 | 0.115 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET00718 | DBMET00718 | |
| 0.026 | 0.13 | 0.272 | Selectin antagonist | 0.272 0.007 DBMET00718 | DBMET00718 | |
| 0.142 | 0.25 | 0.306 | Immunomodulator | 0.295 0.085 DBMET00718 0.306 0.079 DBMET00720 | DBMET00720 | |
| 0.113 | 0.222 | 0.212 | Vasodilator | 0.212 0.095 DBMET00718 | DBMET00718 | |
| 0.051 | 0.165 | 0.116 | Expectorant | 0.116 0.054 DBMET00720 | DBMET00720 | |
| 0.008 | 0.123 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET00718 | DBMET00718 | |
| 0.217 | 0.346 | 0.298 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.298 0.216 DBMET00720 | DBMET00720 | |
| 0.094 | 0.232 | 0.129 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.129 0.119 DBMET00720 | DBMET00720 | |
| 0.016 | 0.162 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00718 | DBMET00718 | |
| 0.061 | 0.218 | 0.096 | Adenylate kinase inhibitor | 0.096 0.074 DBMET00720 | DBMET00720 | |
| 0.089 | 0.272 | 0.119 | Death-associated protein kinase 1 inhibitor | 0.119 0.118 DBMET00720 | DBMET00720 | |
| 0.049 | 0.242 | 0.142 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.142 0.094 DBMET00720 | DBMET00720 | |
| 0.031 | 0.281 | 0.112 | Topoisomerase II inhibitor | 0.098 0.088 DBMET00718 0.112 0.075 DBMET00720 | DBMET00720 | |
| 0.021 | 0.281 | 0.052 | Heparanase inhibitor | 0.052 0.039 DBMET00718 | DBMET00718 | |
| 0.059 | 0.323 | 0.193 | Interleukin agonist | 0.193 0.127 DBMET00720 | DBMET00720 | |
| 0.062 | 0.359 | 0.122 | Adenylate cyclase stimulant | 0.122 0.119 DBMET00720 | DBMET00720 | |
| 0.051 | 0.359 | 0.218 | Nitric oxide antagonist | 0.218 0.061 DBMET00718 | DBMET00718 | |
| 0.098 | 0.432 | 0.286 | Apoptosis antagonist | 0.286 0.095 DBMET00718 | DBMET00718 | |
| 0.039 | 0.483 | 0.26 | Tumour necrosis factor alpha release inhibitor | 0.26 0.07 DBMET00718 | DBMET00718 | |
| 0.014 | 0.485 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.061 DBMET00720 | DBMET00720 | |
| 0.042 | 0.555 | 0.203 | Antithrombotic | 0.203 0.173 DBMET00718 | DBMET00718 | |
| 0.024 | 0.567 | 0.122 | Toll-Like receptor 4 antagonist | 0.122 0.042 DBMET00718 | DBMET00718 | |
| 0.016 | 0.612 | 0.233 | Free radical scavenger | 0.233 0.076 DBMET00718 | DBMET00718 | |
| 0.033 | 0.676 | 0.225 | Hypoglycemic | 0.225 0.093 DBMET00718 | DBMET00718 | |
| 0.021 | 0.694 | 0.143 | Platelet adhesion inhibitor | 0.143 0.115 DBMET00718 | DBMET00718 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |